...The drug industry can’t absolve itself by disavowing the egregious actions of outliers such as Marathon Pharmaceuticals LLC...
...Tokyo, Japan Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Kaiser Family Foundation, Menlo Park. Calif. Marathon Pharmaceuticals LLC...

...the EU. PTC has another DMD therapy, the steroid Emflaza deflazacort, which it acquired from Marathon Pharmaceuticals LLC...
...PTC gained $0.76 to $14.31 on Tuesday, while Sarepta was off $0.06 to $31.50. Mary Romeo Emflaza Exondys 51 Translarna Marathon Pharmaceuticals LLC PTC...

...other vouchers FDA has granted remain unused (see BioCentury, June 1, 2015) . In February, Marathon Pharmaceuticals LLC...
...guselkumab to treat psoriasis. Mary Romeo bictegravir Brineura Edurant Emflaza emtricitabine/tenofovir alafenamide Kanuma Sirturo Strensiq Tivicay Alexion Pharmaceuticals Inc. Biogen Inc. BioMarin Pharmaceutical Inc. Gilead Sciences Inc. GlaxoSmithKline plc Johnson & Johnson Marathon Pharmaceuticals LLC Pfizer...

...CureDuchenne told BioCentury an average DMD patient weighs about 40 kg. PTC acquired Emflaza from Marathon Pharmaceuticals LLC...

...PhRMA also eliminated its category of associate members, which included 15 companies. Among them were Marathon Pharmaceuticals LLC...
...18) . Becky Simon AMAG Pharmaceuticals Inc. BioMarin Pharmaceutical Inc. Esperion Therapeutics Inc. Horizon Pharma plc Jazz Pharmaceuticals plc Leadiant Biosciences S.p.A. Mallinckrodt plc Marathon Pharmaceuticals LLC Pharmaceutical...

...BioCentury an average DMD patient weighs about 40 kg. PTC acquired Emflaza last month from Marathon Pharmaceuticals LLC...
...date. Translarna is a small molecule that facilitates complete translation of proteins containing nonsense mutations. Chris Lieu Emflaza Translarna Marathon Pharmaceuticals LLC PTC...

...approvals1Q setbacks Selected 1Q approvals. (A) PTC Therapeutics Inc. (NASDAQ:PTCT) is acquiring Emflaza deflazacort from Marathon Pharmaceuticals...
...treat carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy when SSA is inadequate Marathon Pharmaceuticals LLC...

...inquiries. Marathon Pharmaceuticals LLC , Northbrook, Ill. PTC Therapeutics Inc. (NASDAQ:PTCT), South Plainfield, N.J. Business: Musculoskeletal Jaime De Leon ataluren deflazacort Emflaza MP-104 Translarna Marathon Pharmaceuticals LLC PTC...

...criticism over the drug's proposed price, PTC Therapeutics Inc. (NASDAQ:PTCT) is acquiring Emflaza deflazacort from Marathon Pharmaceuticals LLC...
...Translarna is a small molecule that facilitates complete translation of proteins containing nonsense mutations. Jaime De Leon ataluren deflazacort Emflaza MP-104 Translarna Marathon Pharmaceuticals LLC PTC...

...Rep. Elijah Cummings (D-Md.) asked the agency to defend its approval of Emflaza deflazacort from Marathon Pharmaceuticals LLC...
...it expects over its seven years of market exclusivity (see BioCentury Extra, March 6) . Becky Simon Emflaza Marathon Pharmaceuticals LLC...